Literature DB >> 18609418

Cognitive impairment of executive function as a core symptom of schizophrenia.

Thomas Wobrock1, Ullrich K H Ecker, Harald Scherk, Thomas Schneider-Axmann, Peter Falkai, Oliver Gruber.   

Abstract

Cognitive dysfunction is a common finding in schizophrenia. Nevertheless the specific pattern of neuropsychological impairment in schizophrenia compared to other severe mental illnesses has not been intensively studied. Twenty-four patients with schizophrenia belonging to different stages of the disease (11 first-episode patients, 13 patients with multiple episodes), 18 patients with bipolar disorder and 23 healthy control subjects underwent standardized neuropsychological assessment. Statistical analysis of covariance (ANCOVA) demonstrated that, compared to control subjects, patients with schizophrenia performed significantly worse in the trail-making test (P = 0.012), verbal fluency (category letter, P = 0.004), verbal learning/memory (P = 0.005), and the Wisconsin Card Sorting Test (WCST) (P = 0.004 for administered trials; P = 0.025 for perseverative responses, T value) indicating significant deficits in attention and psychomotor performance, and in particular in verbal working memory and cognitive flexibility for schizophrenic patients. A significant difference between schizophrenic and bipolar patients was found only in the WCST. Schizophrenic patients made significantly more perseverative responses (P = 0.002, ANCOVA), indicating a more pronounced and specific deficit in cognitive flexibility and frontally based executive function. In conclusion, these results may suggest a cognitive endophenotype in schizophrenia and underline the role of the prefrontal cortex in schizophrenic pathophysiology.

Entities:  

Mesh:

Year:  2009        PMID: 18609418     DOI: 10.1080/15622970701849986

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  19 in total

1.  Wellness within illness: happiness in schizophrenia.

Authors:  Barton W Palmer; Averria Sirkin Martin; Colin A Depp; Danielle K Glorioso; Dilip V Jeste
Journal:  Schizophr Res       Date:  2014-08-18       Impact factor: 4.939

Review 2.  Neuroinflammation and synaptic loss.

Authors:  Jagadeesh S Rao; Matthew Kellom; Hyung-Wook Kim; Stanley I Rapoport; Edmund A Reese
Journal:  Neurochem Res       Date:  2012-02-07       Impact factor: 3.996

3.  Sequential reversal learning: a new touchscreen schedule for assessing cognitive flexibility in mice.

Authors:  Anna U Odland; Rune Sandahl; Jesper T Andreasen
Journal:  Psychopharmacology (Berl)       Date:  2020-10-30       Impact factor: 4.530

Review 4.  Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius.

Authors:  Tiffany A Greenwood
Journal:  Mol Neuropsychiatry       Date:  2016-12-09

5.  Cognitive profiles in persons with chronic schizophrenia.

Authors:  Sharron E Dawes; Dilip V Jeste; Barton W Palmer
Journal:  J Clin Exp Neuropsychol       Date:  2011-06-28       Impact factor: 2.475

6.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

Authors:  Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-10-17       Impact factor: 4.105

7.  Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia.

Authors:  Tejas S Bhojraj; Vaibhav A Diwadkar; John A Sweeney; Konasale M Prasad; Shaun M Eack; Debra M Montrose; Matcheri S Keshavan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-01-29       Impact factor: 5.067

8.  Serum glutamine, set-shifting ability and anorexia nervosa.

Authors:  Michiko Nakazato; Kenji Hashimoto; Ulrike Schmidt; Kate Tchanturia; Iain C Campbell; David A Collier; Masaomi Iyo; Janet Treasure
Journal:  Ann Gen Psychiatry       Date:  2010-06-25       Impact factor: 3.455

9.  Do people with schizophrenia have differential impairment in episodic memory and/or working memory relative to other cognitive abilities?

Authors:  Barton W Palmer; Gauri N Savla; Ian E Fellows; Elizabeth W Twamley; Dilip V Jeste; Jonathan P Lacro
Journal:  Schizophr Res       Date:  2009-11-27       Impact factor: 4.939

10.  Abnormalities in chemokine levels in schizophrenia and their clinical correlates.

Authors:  Suzi Hong; Ellen E Lee; Averria Sirkin Martin; Benchawanna Soontornniyomkij; Virawudh Soontornniyomkij; Cristian L Achim; Chase Reuter; Michael R Irwin; Lisa T Eyler; Dilip V Jeste
Journal:  Schizophr Res       Date:  2016-09-17       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.